Nutrien Ltd.

Nutrien Ltd. Earnings Recaps

NTR Materials 2 recaps
Next earnings: February 17, 2027 (estimated) · full calendar
Q3 2026 Nov 7, 2026

Nutrien shares fell 0.8% after the earnings release, a relatively muted move. The transcript points to a mixed quarter: record-near potash volumes and higher cash returns were tempered by geopolitical volatility weighing on retail crop nutrient volumes and higher fuel costs; the company maintained its 2026 potash shipment forecast.

Key takeaways
  • Adjusted EBITDA was $1.31 billion in the third quarter and $4.85 billion in the first nine months; operating cash flow rose 17% year to date versus the prior year.
  • Potash generated $730 million of third-quarter adjusted EBITDA, with sales volumes near record levels; ore tons cut using automation reached 53%.
  • Retail adjusted EBITDA increased over the first nine months, supported by proprietary product margins and Australian livestock markets, but geopolitical volatility lowered crop nutrient sales volumes and fuel costs increased.
  • Nutrien returned $1.3 billion to shareholders through dividends and repurchases in the first nine months, with share repurchases up 36%.
  • The company plans to shut its White Springs phosphate operations in the second quarter of 2027, citing rising costs and capital needs, while retaining and optimizing Aurora and its integrated upgrade facilities.
Q2 2026 Aug 8, 2026

Nutrien’s shares fell 3.7% after the earnings release, primarily driven by cautious nitrogen market outlook and deceleration in global urea prices during a seasonally weak demand period exacerbated by geopolitical uncertainty.

Key takeaways
  • Adjusted EBITDA reached $2.4 billion in Q2 and $3.5 billion in H1 2026, up 6% year-over-year.
  • Potash volumes hit record levels, with controllable cash costs flat YoY and automation enabling cost discipline.
  • Proprietary crop nutrients gross margin grew 10%, supported by targeted capacity expansions despite softer overall fertilizer demand.
  • Nitrogen segment faced price softness in Q2 due to seasonal factors and geopolitical disruptions, though the North American assets remain cost advantaged.
  • Continued portfolio optimization with $1 billion in gross proceeds generated from asset divestitures since late 2024; strategic reviews underway for phosphate and other segments.